// App-Quantinova.ai

5 : Thymoglobulin (ATG) Induction vs. Campath vs. Simulect in DCD Kidneys in UK; Induction Regimes Play a Role after All

Researchers

Presenter

  • A. Asderakis

Principal Investigators

  • T. Sabbah

  • J. Watkins

  • L. Szab

  • D. Elker

  • A. M. Ilham

  • E. Ablorsu

  • M. Stephens

  • U. Khalid

  • R. Chavez

Medical Centers

  • Cardiff Transplant Unit, University Hospital for Wales, Cardiff, United Kingdom

  • Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Transplant rejection

Biomarkers

  • N/A

Drug/Treatment

  • Simulect

  • Basiliximab

  • Alemtuzumab

Outcome

  • N/A

Study Design

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved